Attached files

file filename
8-K - 8-K - STERICYCLE INCbo8k1215.htm
EXHIBIT 99.1

FOR FURTHER INFORMATION CONTACT:        

Investor Relations 847-607-2012
 
Conference call to be held February 4, 2016 4:00 p.m. Central time – Dial 866-516-6872 at least 5 minutes before start time. If you are unable to participate on the call, a replay will be available through March 4th by dialing 855-859-2056, access code 21498985. To hear a live simulcast of the call or access the audio archive, visit the investor relations page on www.stericycle.com.

STERICYCLE, INC. REPORTS RESULTS
FOR THE FOURTH QUARTER AND FULL YEAR ENDED 2015

Lake Forest, Illinois, February 4, 2016—Stericycle, Inc. (NASDAQ:SRCL) today reported financial results for the fourth quarter and the full year of 2015.

FOURTH QUARTER RESULTS
Revenues for the quarter ended December 31, 2015 were $888.3 million, up $211.4 million or 31.2%, from $676.9 million in the fourth quarter last year. Acquisitions contributed approximately $200.0 million in revenues to the current period’s growth. Revenues increased 35.2% compared to the prior period when adjusted for unfavorable foreign exchange impact of $26.9 million.
Gross profit, reported in accordance with U.S. generally accepted accounting principles (“GAAP”), was $380.4 million, up 33.5% from $285.0 million in the fourth quarter last year. GAAP gross profit as a percent of revenues was 42.8% compared to 42.1% in the fourth quarter last year. Non-GAAP gross profit, when adjusted for various items identified in the second of the following tables, was $380.9 million, up 33.5% from $285.4 million in the fourth quarter last year. Non-GAAP gross profit as a percent of revenues was 42.9% compared to 42.2% in the fourth quarter last year.
GAAP earnings per diluted share decreased 16.4% to $0.80 from $0.96 in the fourth quarter last year. Non-GAAP earnings per diluted share, when adjusted for various items identified in the third of the following tables, decreased 0.9% to $1.11 from $1.12 in the fourth quarter last year. See tables below.

FULL-YEAR RESULTS
Revenues for the full year 2015 were $2.99 billion, up $430.3 million or 16.8%, from $2.56 billion in the same period last year. Acquisitions contributed approximately $378.5 million in revenues to the current year’s growth. Revenues increased 21.2% compared with the prior period when adjusted for unfavorable foreign exchange impact of $110.2 million.
GAAP gross profit was $1.27 billion, up 15.7% from $1.09 billion in the same period last year. GAAP gross profit as a percent of revenues was 42.4% compared to 42.8% in the same period last year. Non-GAAP gross profit, when adjusted for various items identified in the second of the following tables, was $1.27 billion, up 15.5% from $1.10 billion in the same period as last year. Non-GAAP gross profit as a percent of revenues was 42.5% compared to 42.9% in the same period last year.
GAAP earnings per diluted share decreased 21.7% to $2.96 from $3.79 in 2014. Non-GAAP earnings per diluted share, when adjusted for various items identified in the third of the following tables, increased 3.0% to $4.40 from $4.27. See tables below.


1



The following table shows our calculations of organic revenue growth (in millions)(1) 
 
Three Months Ended December 31,
 
Years Ended December 31,
 
 
 
Change
 
 
 
Change
 
2015
2014
$
%
 
2015
2014
$
%
Total As Reported Revenues (GAAP)
$
888.3

$
676.9

$
211.4

31.2
%
 
$
2,985.9

$
2,555.6

$
430.3

16.8
%
Adjustment for Foreign Exchange
26.9

 
26.9

 
 
110.2

 
110.2

 
Subtotal (non-GAAP):
915.2

676.9

238.2

35.2
%
 
3,096.1

2,555.6

540.5

21.2
%
 
 
 
 
 
 
 
 
 
 
Adjustment for Acquisitions
(206.6)

(6.7)

(200.0)

 
 
(439.1)

(60.6)

(378.5)

 
Adjustment for Regulated Returns and
Recall Management Services
(20.4)

(16.1)

(4.4)

 
 
(87.4)

(80.5)

(7.0)

 
Total revenues, as adjusted (non-GAAP):
$
688.1

$
654.2

$
33.9

5.2
%
 
$
2,569.6

$
2,414.5

$
155.1

6.4
%
 
 
 
 
 
 
 
 
 
 
Domestic/ International Breakdown:
 
 
 
 
 
 
 
 
 
Domestic Revenues
$
651.1

$
477.6

$
173.5

36.3
%
 
$
2,165.0

$
1,788.4

$
376.6

21.1
%
International Revenues
237.2

199.3

37.9

19.0
%
 
820.9

767.2

53.7

7.0
%
Total As Reported Revenues (GAAP)
$
888.3

$
676.9

$
211.4

31.2
%
 
$
2,985.9

$
2,555.6

$
430.3

16.8
%

(1) For internal purposes, we exclude the impact of foreign exchange, revenues attributed to acquisitions closed within the preceding 12 months, and revenue from our regulated returns and recall management services when we evaluate organic revenue growth.

This table and the Company’s internal use of non-GAAP adjusted revenues are not intended to imply, and should not be interpreted as implying, that non-GAAP adjusted revenues are a better measure of internal growth or the Company’s performance, as compared to GAAP revenues.


Table to reconcile GAAP Gross Profit to Non-GAAP Gross Profit (in millions)(2) 

 
Three Months Ended December 31,
 
Years Ended December 31,
 
2015
 
2014
 
2015
 
2014
 
$
% of Rev
 
$
% of Rev
 
$
% of Rev
 
$
% of Rev
GAAP Gross Profit

$380.4

42.8
%
 

$285.0

42.1
%
 

$1,266.2

42.4
%
 

$1,094.4

42.8
%
Plant Conversion Expenses
0.5

0.1
%
 
0.4

0.1
%
 
1.5

0.1
%
 
2.9

0.1
%
Non-GAAP Gross Profit

$380.9

42.9
%
 

$285.4

42.2
%
 

$1,267.7

42.5
%
 

$1,097.3

42.9
%

(2) In accordance with GAAP, reported Gross Profit includes the impact of the items identified in this table. For internal purposes, including the determination of management compensation, the Company excludes these items from results when evaluating operating performance.

This table and the Company’s internal use of non-GAAP Gross Profit are not intended to imply, and should not be interpreted as implying, that non-GAAP Gross Profit is a better measure of performance than GAAP Gross Profit.



2




Table to reconcile GAAP EPS to Non-GAAP EPS(3) 
 
 
Three Months Ended December 31,
 
Years Ended December 31,
 
 
 
Change
 
 
 
 
Change
 
2015
2014
$
%
 
2015
2014
$
%
GAAP EPS
$
0.80

$
0.96

$
(0.16
)
(16.4
)%
 
$
2.96

$
3.79

$
(0.82
)
(21.7
)%
Acquisition Expenses a
0.00

0.03

 
 
 
0.34

0.14

 
 
Integration Expenses a
0.15

0.08

 
 
 
0.39

0.19

 
 
Litigation Expenses a
0.05

0.02

 
 
 
0.46

0.05

 
 
Changes in Fair Value of Contingent
  Consideration a
--

(0.06)

 
 
 
(0.01)

(0.02)

 
 
Impairment of intangible assets a
0.02

--

 
 
 
0.02

--

 
 
Plant Conversion and Restructuring
  Expenses a
0.04

0.09

 
 
 
0.18

0.12

 
 
Add Back Convertible Preferred
  Stock Dividend b
0.12

--

 
 
 
0.14

--

 
 
Reallocation of EPS Related to
  Convertible Preferred Stock If-
  Converted Method b
(0.07)

--

 
 
 
(0.08)

--

 
 
Non-GAAP EPS (Adjusted)
$
1.11

$
1.12

$
(0.01
)
(0.9
)%
 
$
4.40

$
4.27

$
0.13

3.0
 %
Diluted Weighted Average Number
  of Common Shares Outstanding
  Under If-Converted Method
91,430,668

86,194,513

 
 
 
87,810,927

86,233,612

 
 

(3a) In accordance with GAAP, reported earnings per diluted share (EPS) include the after-tax impact of the items identified. For internal purposes, including the determination of management compensation, the Company excludes these items from results when evaluating operating performance.

(3b) For purposes of determining non-GAAP EPS, the Company (1) adds back the mandatory convertible preferred stock dividend; and (2) deducts the EPS impact of the items identified above and the mandatory convertible preferred stock dividend using the “if-converted” method. Under the “if-converted” method used in determining our non-GAAP EPS, the items identified above and the preferred dividend applicable to the convertible preferred stock is added back to net income attributable to Stericycle, the numerator. The Mandatory Convertible Preferred shares are assumed to be converted to common shares at the beginning of the period or, if later, at the time of issuance, and the resulting common shares are included in the denominator.


This table and the Company’s internal use of non-GAAP earnings per diluted share are not intended to imply, and should not be interpreted as implying, that non-GAAP earnings per diluted share is a better measure of performance than GAAP earnings per diluted share.
 

Cash flow from operations was $390.3 million and $448.5 million for the full years of 2015 and 2014, respectively.

For more information about Stericycle, please visit our website at www.stericycle.com.


Safe Harbor Statement: This press release may contain forward-looking statements that involve risks and uncertainties, some of which are beyond our control (for example, general economic and market conditions). Our actual results could differ significantly from the results described in the forward-looking statements. Factors that could cause such differences include changes in governmental regulation of the collection, transportation, treatment and disposal of regulated waste or the proper handling and protection of personal and confidential information, increases in transportation and other operating costs, the level of governmental enforcement of regulations governing regulated waste collection and treatment or the proper handling and protection of personal and confidential information, our obligations to service our substantial indebtedness and to comply with the covenants and restrictions contained in our private placement notes, term loan credit facility and revolving credit facility, our ability to execute our acquisition strategy and to integrate acquired businesses, competition and demand for services in the regulated waste and secure information destruction industries, political, economic and currency risks related to our foreign operations, impairments of goodwill

3



or other indefinite-lived intangibles, variability in the demand for services we provide on a project or non-recurring basis, exposure to environmental liabilities, fluctuations in the price we receive for the sale of paper, disruptions in or attacks on our information technology systems, compliance with existing and future legal and regulatory requirements, as well as other factors described in our filings with the U.S. Securities and Exchange Commission, including our most recently filed Annual Report on Form 10-K. As a result, past financial performance should not be considered a reliable indicator of future performance, and investors should not use historical trends to anticipate future results or trends. We make no commitment to disclose any subsequent revisions to forward-looking statements.


4




STERICYCLE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS)
(UNAUDITED)
 
December 31,
 
2015
 
2014
ASSETS
 
 
 
Current Assets:
 
 
 
Cash and cash equivalents
$
55,634

 
$
22,236

Short-term investments
69

 
380

Accounts receivable, net
614,494

 
465,473

Prepaid expenses
46,740

 
30,632

Other current assets
44,891

 
33,173

Total Current Assets
761,828

 
551,894

Property, plant and equipment, net
665,602

 
460,408

Goodwill
3,676,326

 
2,418,832

Intangible assets, net
1,833,561

 
909,645

Other assets
43,553

 
32,523

Total Assets
$
6,980,870

 
$
4,373,302

 
 
 
 
LIABILITIES AND EQUITY
 
 
 
Current liabilities:
 
 
 
Current portion of long-term debt
$
161,409

 
$
131,969

Accounts payable
149,202

 
114,596

Accrued liabilities
196,087

 
131,743

Deferred revenues
16,989

 
21,624

Other current liabilities
64,105

 
60,975

Total Current Liabilities
587,792

 
460,907

Long-term debt, net of current portion
3,052,639

 
1,527,246

Deferred income taxes
517,587

 
403,847

Other liabilities
76,667

 
64,117

Equity:
 
 
 
Mandatory convertible preferred stock
8

 

Common stock
849

 
849

Additional paid-in capital
1,141,999

 
289,211

Accumulated other comprehensive loss
(282,632
)
 
(138,419
)
Retained earnings
1,868,014

 
1,743,371

Total Stericycle, Inc. Equity
2,728,238

 
1,895,012

Noncontrolling interest
17,947

 
22,173

Total Equity
2,746,185

 
1,917,185

Total Liabilities and Equity
$
6,980,870

 
$
4,373,302


5



STERICYCLE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
(UNAUDITED)
 
Three Months Ended December 31,
 
Years Ended December 31,
 
2015
 
2014
 
2015
 
2014
 
$
 
% of Rev
 
$
 
% of Rev
 
$
 
% of Rev
 
$
 
% of Rev
Revenues
$
888,304

 
100.0
 %
 
$
676,947

 
100.0
 %
 
$
2,985,908

 
100.0
 %
 
$
2,555,601

 
100.0
 %
Cost of revenues ("COR") - exclusive of depreciation and adjusting items shown below
488,523

 
55.0
 %
 
378,182

 
55.9
 %
 
1,656,573

 
55.5
 %
 
1,401,797

 
54.9
 %
Depreciation
18,919

 
2.1
 %
 
13,415

 
2.0
 %
 
61,642

 
2.1
 %
 
56,478

 
2.2
 %
Total cost of revenues
507,442

 
57.1
 %
 
391,597

 
57.8
 %
 
1,718,215

 
57.5
 %
 
1,458,275

 
57.1
 %
Gross profit (non-GAAP)
380,862

 
42.9
 %
 
285,350

 
42.2
 %
 
1,267,693

 
42.5
 %
 
1,097,326

 
42.9
 %
Selling, general and administrative expenses ("SG&A") - exclusive of depreciation, amortization, and adjusting items shown below
177,556

 
20.0
 %
 
112,563

 
16.6
 %
 
539,944

 
18.1
 %
 
433,865

 
17.0
 %
Depreciation
7,519

 
0.8
 %
 
3,121

 
0.5
 %
 
20,272

 
0.7
 %
 
15,446

 
0.6
 %
Amortization
18,541

 
2.1
 %
 
8,478

 
1.3
 %
 
45,498

 
1.5
 %
 
32,692

 
1.3
 %
Total SG&A expense
203,616

 
22.9
 %
 
124,162

 
18.3
 %
 
605,714

 
20.3
 %
 
482,003

 
18.9
 %
Income from operations (non-GAAP) - exclusive of adjusting items shown below
177,246

 
20.0
 %
 
161,188

 
23.8
 %
 
661,979

 
22.2
 %
 
615,323

 
24.1
 %
Adjusting items:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plant conversion expenses (COR)
507

 
0.1
 %
 
381

 
0.1
 %
 
1,508

 
0.1
 %
 
2,915

 
0.1
 %
Acquisition expenses (SG&A)
(818
)
 
-0.1
 %
 
2,661

 
0.4
 %
 
39,138

 
1.3
 %
 
13,333

 
0.5
 %
Integration expenses (SG&A)
20,432

 
2.3
 %
 
11,343

 
1.7
 %
 
51,689

 
1.7
 %
 
25,968

 
1.0
 %
Change in fair value of contingent consideration (SG&A)

 
0.0
 %
 
(5,405
)
 
-0.8
 %
 
(640
)
 
0.0
 %
 
(1,452
)
 
-0.1
 %
Impairment of intangible assets (SG&A)
1,781

 
0.2
 %
 

 
0.0
 %
 
1,781

 
0.1
 %
 

 
0.0
 %
Restructuring and plant conversion expenses (SG&A)
4,160

 
0.5
 %
 
10,114

 
1.5
 %
 
21,240

 
0.7
 %
 
11,649

 
0.5
 %
Litigation expenses (SG&A)
645

 
0.1
 %
 
3,331

 
0.5
 %
 
59,651

 
2.0
 %
 
6,574

 
0.3
 %
Income from operations (GAAP)
150,539

 
16.9
 %
 
138,763

 
20.5
 %
 
487,612

 
16.3
 %
 
556,336

 
21.8
 %
Other income (expense):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest expense, net
(24,908
)
 
-2.8
 %
 
(18,139
)
 
-2.7
 %
 
(77,274
)
 
-2.6
 %
 
(66,022
)
 
-2.6
 %
Other income/ (expense), net
4,525

 
0.5
 %
 
(1,177
)
 
-0.2
 %
 
569

 
0.0
 %
 
(2,746
)
 
-0.1
 %
Total other expense
(20,383
)
 
-2.3
 %
 
(19,316
)
 
-2.9
 %
 
(76,705
)
 
-2.6
 %
 
(68,768
)
 
-2.7
 %
Income before income taxes
130,156

 
14.7
 %
 
119,447

 
17.6
 %
 
410,907

 
13.8
 %
 
487,568

 
19.1
 %
Income tax expense
51,537

 
5.8
 %
 
36,789

 
5.4
 %
 
142,862

 
4.8
 %
 
159,422

 
6.2
 %
Net income
78,619

 
8.9
 %
 
82,658

 
12.2
 %
 
268,045

 
9.0
 %
 
328,146

 
12.8
 %
Less: net (loss)/ income attributable to noncontrolling interests
(289
)
 
0.0
 %
 
132

 
0.0
 %
 
967

 
0.0
 %
 
1,690

 
0.1
 %
Net income attributable to Stericycle, Inc.
78,908

 
8.9
 %
 
82,526

 
12.2
 %
 
267,078

 
8.9
 %
 
326,456

 
12.8
 %
Less: mandatory convertible preferred stock dividend
10,107

 
1.1
 %
 

 
0.0
 %
 
11,791

 
0.4
 %
 

 
0.0
 %
Net income attributable to Stericycle, Inc. common shareholders
$
68,801

 
7.7
 %
 
$
82,526

 
12.2
 %
 
$
255,287

 
8.5
 %
 
$
326,456

 
12.8
 %
Earnings per share- diluted
$
0.80

 
 
 
$
0.96

 
 
 
$
2.96

 
 
 
$
3.79

 
 
Weighted average number of common shares outstanding - diluted
85,949,461

 
 
 
86,194,513

 
 
 
86,162,609

 
 
 
86,233,612

 
 

6



STERICYCLE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
(UNAUDITED)
  
December 31,
 
2015
 
2014
OPERATING ACTIVITIES:
 
 
 
Net income
$
268,045

 
$
328,146

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Stock compensation expense
21,750

 
17,773

Excess tax benefit of stock options exercised
(16,897
)
 
(17,906
)
Depreciation
81,914

 
71,924

Amortization
45,498

 
32,692

Deferred income taxes
(6,715
)
 
16,550

Other, net
7,467

 
8,932

Changes in operating assets and liabilities, net of effect of acquisitions:
 
 
 
Accounts receivable
(55,890
)
 
(34,116
)
Accounts payable
26,366

 
(5,712
)
Accrued liabilities
23,133

 
21,279

Deferred revenues
(4,615
)
 
1,017

Other assets and liabilities
294

 
7,921

Net cash provided by operating activities
390,350

 
448,500

INVESTING ACTIVITIES:
 
 
 
Payments for acquisitions, net of cash acquired
(2,419,437
)
 
(374,321
)
Proceeds from/ (purchases of) investments
294

 
(1,957
)
Capital expenditures
(114,761
)
 
(86,496
)
Net cash used in investing activities
(2,533,904
)
 
(462,774
)
FINANCING ACTIVITIES:
 
 
 
Repayments of long-term debt and other obligations
(93,172
)
 
(101,231
)
Proceeds from foreign bank debt
53,747

 
205,086

Repayments of foreign bank debt
(87,308
)
 
(193,284
)
Proceeds from term loan
1,550,000

 

Repayments of term loan
(300,000
)
 

Proceeds from private placement of long-term note
600,000

 

Repayments of private placement of long-term note
(100,000
)
 

Proceeds from senior credit facility
1,907,402

 
1,413,026

Repayments of senior credit facility
(2,004,385
)
 
(1,216,031
)
Repayments of capital lease obligations
(3,865
)
 
(5,826
)
Payments of deferred financing costs
(9,903
)
 
(2,280
)
Payment for hedge
(8,833
)
 

Purchases and cancellations of treasury stock
(130,576
)
 
(194,066
)
Proceeds from issuance of mandatory convertible preferred stock
746,900

 

Dividends paid on mandatory convertible preferred stock
(10,106
)
 

Proceeds from issuances of common stock
60,124

 
51,852

Excess tax benefit of stock options exercised
16,897

 
17,906

Payments to noncontrolling interests
(5,714
)
 
(5,201
)
Net cash provided by/ (used in) financing activities
2,181,208

 
(30,049
)
Effect of exchange rate changes on cash
(4,256
)
 
(608
)
Net increase/ (decrease) in cash and cash equivalents
33,398

 
(44,931
)
Cash and cash equivalents at beginning of period
22,236

 
67,167

Cash and cash equivalents at end of period
$
55,634

 
$
22,236

 
 
 
 
NON-CASH ACTIVITIES:
 
 
 
Issuances of obligations for acquisitions
$
80,189

 
$
145,938


7